Rebollar-Vega RG, Arriaga-Canon C, de la Rosa-Velázquez A

Idioma: Ingles.
Referencias bibliográficas: 11
Paginas: 153-157
Archivo PDF: 218.28 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Rehm HL, Bale SJ, Bayrak-Toydemir P, et al. ACMG clinical laboratory standards for next-generation sequencing. Genet Med. 2013;15:733-47.

2. Shen T, Pajaro-Van de Stadt SH, Yeat NC, Lin JC. Clinical applications of next generation sequencing in cancer: from panels, to exomes, to genomes. Front Genet. 2015;6:215.

3. Slavin TP, Niell-Swiller M, Solomon I, et al. Clinical application of multigene panels: challenges of next-generation counseling and cancer risk management. Front Oncol. 2015;5:208.

4. Hyman DM, Taylor BS, Baselga J. Implementing genome-driven oncology. Cell. 2017;168:584-99.

5. de Unamuno Bustos B, Murría Estal R, Pérez Simo G, et al. Towards personalized medicine in melanoma: implementation of a clinical next-generation sequencing panel. Sci Rep. 2017;7:495.

6. Kumar-Sinha C, Chinnaiyan AM. Precision oncology in the age of integrative genomics. Nat Biotechnol. 2018;36:46-60.

7. Abou Tayoun AN, Spinner NB, Rehm HL, Green RC Bianchi DW. Prenatal DNA sequencing: clinical, counseling, and diagnostic laboratory considerations. Prenat Diagn. 2018;38:26-32.

8. Domínguez-Vigil IG, Moreno-Martínez AK, Wang JY, Roehrl MH, Barrera-Saldaña HA. The dawn of the liquid biopsy in the fight against cancer. Oncotarget. 2017;9:2912-22.

9. Deurenberg RH, Bathoorn E, Chlebowicz MA, et al. Application of next generation sequencing in clinical microbiology and infection prevention. J Biotechnol. 2017;243:16-24.

10. Zhou M, Gao D, Chai X, et al. Application of high-throughput, high-resolution and cost-effective next generation sequencingbased large-scale HLA typing in donor registry. Tissue Antigens. 2015;85:20-8.

11. Cummings CA, Peters E, Lacroix L, Andre F, Lackner MR. The role of next-generation sequencing in enabling personalized oncology therapy. Clin Transl Sci. 2016;9:283-92.